Division of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0680, USA.
Subst Use Misuse. 2010;45(1-2):116-33. doi: 10.3109/10826080902869620.
This study identified sociodemographic factors, drug using practices, sexual behaviors, and motivational factors associated with binge (a period of uninterrupted) methamphetamine (MA) use among heterosexual MA users.
The FASTLANE study provided cross-sectional data collected by audio computer-assisted self-interview (ACASI) between June 2001 and August 2004 from 451 HIV-negative MA users in San Diego, California, USA who had engaged in unprotected sex and used MA in the previous two months.
The study sample was 67.8% male, 49.4% Caucasian, 26.8% African-American, and 12.8% Hispanic with a mean age of 36.6 years; 183 (40.5%) reported binge use in the past 2 months. Compared with non-binge users, binge users of MA were more likely to report risky drug use and sex behaviors and differed in motivations to initiate and currently use MA. The final logistic regression model for binge use included more days of MA use in the last month, ever treated for MA use, injection drug use, higher Beck Depression Inventory score, "experimentation" as a motivation for initiating MA use, and engaging in sex marathons while high on MA. HIV prevention efforts should differentiate and address these differences in motivations for MA use and the associated HIV-risk sex and drug use behaviors as key targets for effective intervention.
本研究旨在确定与异性恋甲基苯丙胺(MA)使用者 binge(一段时间内不间断使用)相关的社会人口因素、药物使用行为、性行为以及动机因素。
FASTLANE 研究提供了 2001 年 6 月至 2004 年 8 月期间在美国加利福尼亚州圣地亚哥收集的横断面数据,通过音频计算机辅助自我访谈(ACASI),共纳入 451 名 HIV 阴性、过去两个月内有过无保护性行为且使用过 MA 的 MA 使用者。
研究样本中 67.8%为男性,49.4%为白种人,26.8%为非裔美国人,12.8%为西班牙裔,平均年龄为 36.6 岁;183 名(40.5%)报告在过去 2 个月内有 binge 使用 MA。与非 binge 使用者相比,binge 使用 MA 者更有可能报告危险的药物使用和性行为,且在开始和当前使用 MA 的动机方面存在差异。binge 使用的最终逻辑回归模型包括过去一个月内 MA 使用的天数、曾经接受过 MA 使用治疗、注射毒品、贝克抑郁量表评分较高、“尝试”作为开始使用 MA 的动机,以及在 MA 作用下进行性马拉松。艾滋病预防工作应区分并解决这些在 MA 使用动机以及与艾滋病风险相关的性和药物使用行为方面的差异,将其作为有效干预的关键目标。